EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
By M. Oelke, A. Bachmann, A. Descazeaud, Mark Emberton, S. Gravas, M. Michel, J. N'Dow, J. Nordling, J. de la Rosette. European Urology, 2013
1,243 citations recorded by the source corpus.
Subfields: Psychiatry and Mental health, Rheumatology, Urology
View Paper: https://www.semanticscholar.org/paper/725b6bf638674136c3c4d97578ba2473dc86c7eb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- J. Cornu
- A. Bachmann
- C. Gratzke
- M. Oelke
- S. Ahyai
- A. Descazeaud
- J. de la Rosette
- P. Gilling
Citations in the corpus
- EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. (2015, background): “PV measurement is important before treatment with 5-ARIs and for selection of an appropriate interventional treatment [35].”
- A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. (2015, methodology): “Surgical intervention is the standard treatment for patients with bothersome LUTS due to benign prostatic obstruction (BPO) unwilling to try medical therapies, in cases where medical therapies were not effective, and in cases of complicated LUTS [1].”